Evidence map›Paper›PMID 38380941›Full record

ArticlemSphere2024

Heme sequestration by hemophilin from

Sam Fulte, Brianna Atto, Arianna McCarty, Kadi J Horn, Jasmina S Redzic, Elan Eisenmesser, Michael Yang, Robyn L Marsh, Stephen Tristram, Sarah E Clark

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cervicovaginal microbial features predictInfection and immunity · 2025
    Article
  3. Article
  4. Article
  5. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
  6. Article
  7. Exploiting haem-iron dependence of nontypeableFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sam FulteDepartment of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0009-0008-8206-2948
Brianna AttoSchool of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.ORCID 0000-0002-3344-9328
Arianna McCartyDepartment of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Kadi J HornDepartment of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jasmina S RedzicDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, USA.
Elan EisenmesserDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, USA.
Michael YangDepartment of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Robyn L MarshSchool of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.
Stephen TristramSchool of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.ORCID 0000-0002-8485-0322
Sarah E ClarkDepartment of Otolaryngology, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID 0000-0002-5975-5032
University of Colorado Denver · USUniversity of Tasmania · AU

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
The global regulation of dynamics and structure mediated by single hydride in a family of reductasesR01GM139892 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI EISENMESSER, ELAN Z · 2021 to 2024
$1.2M
NCI NIH HHS P30 CA046934NIAID NIH HHS R25 AI147376NIGMS NIH HHS R01 GM139892
6 · The paper itself

Abstract

Iron acquisition is a key feature dictating the success of pathogen colonization and infection. Pathogens scavenging iron from the host must contend with other members of the microbiome similarly competing for the limited pool of bioavailable iron, often in the form of heme. In this study, we identify a beneficial role for the heme-binding protein hemophilin (Hpl) produced by the non-pathogenic bacterium IMPORTANCE: The microbiome provides a critical layer of protection against infection with bacterial pathogens. This protection is accomplished through a variety of mechanisms, including interference with pathogen growth and adherence to host cells. In terms of immune defense, another way to prevent pathogens from establishing infections is by limiting the availability of nutrients, referred to as nutritional immunity. Restricting pathogen access to iron is a central component of this approach. Here, we uncovered an example where these two strategies intersect to impede infection with the respiratory tract bacterial pathogen

Indexed as

HaemophilusHaemophilus InfectionsHaemophilus influenzaeHemeHumansIronLungHemeIronHaemophilus haemolyticusHaemophilus influenzaehemehemophilinhemophorelung infectionmicrobiomenasopharyngeal colonizationnutritional immunity

Identifiers

PMID38380941
PMCPMC10964412
OpenAlexW4392004640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.